Idaho Falls is set to become one of the few cities in Idaho to prohibit the sale of kratom, following a City Council vote to ban the psychoactive herb starting July 1. The move comes after Bonneville County’s coroner determined that kratom contributed to six local deaths and accounted for roughly 18 percent of all drug overdose fatalities in the county over the past year and a half.
Coroner Calls Deaths a Wake-Up Call for the Community
Bonneville County Coroner Shante Sanchez has been among the most outspoken local officials on the kratom issue. “This is a wake-up call for our community,” Sanchez said. “To put this into perspective, kratom is now implicated in approximately 18% of the drug overdose fatalities in our county over the last year and a half.”
Kratom is derived from a tropical tree native to Southeast Asia and produces effects that closely resemble opioids. Despite those properties, it remains unregulated at both the state and federal levels, and until now has been widely available in Idaho Falls convenience stores without restriction. The U.S. Food and Drug Administration has warned that the substance can be as much as 13 times more potent than morphine.
The deaths in Bonneville County represent a concentrated version of a problem spreading across Idaho and the nation. Calls to Poison Control centers linked to kratom have surged dramatically over the past decade — rising twelvefold nationally — with approximately 3,400 such calls recorded last year alone. Historically, Idaho has been among the hardest-hit states; the Idaho Poison Control program recorded more kratom-related calls than any other state in the country during the period from 2011 to 2017.
State Lawmakers Fell Short on Restrictions; Local Governments Step In
The Idaho Falls ban fills a gap left by the state legislature, which considered kratom restrictions during the 2026 session but could not assemble enough votes to advance the measure. With no statewide framework in place, local governments have been left to address the issue on their own.
Idaho Falls is not acting in isolation. The Boise County Sheriff’s Office issued a public warning about kratom’s dangers last December, shortly after the Bonneville County coroner’s findings became known. The Panhandle Health District followed with its own advisory in February, signaling that concerns about the substance are growing well beyond the eastern Idaho region. Public health officials and law enforcement alike have raised alarms as the product continues to be marketed and sold without meaningful oversight.
The July 1 effective date gives local businesses a short window to remove kratom products from their shelves. The ban applies specifically to sales within Idaho Falls city limits, meaning residents in surrounding unincorporated areas of Bonneville County would still have access to the product unless additional jurisdictions act.
The push to restrict kratom locally mirrors broader concerns about substances that occupy regulatory gray areas — products that may be legally sold but carry significant public health risks that state and federal regulators have been slow to address. In a county already managing the consequences of opioid-related fatalities, the coroner’s findings that a largely unmonitored herbal product is contributing meaningfully to overdose deaths has galvanized local officials to move where higher levels of government have not.
Idaho Falls residents dealing with other public safety concerns in the area can find additional coverage of recent incidents, including a weapon discharge at Idaho National Laboratory that left an employee hospitalized.
What Comes Next
The July 1 ban takes effect in Idaho Falls, but broader action remains uncertain. State lawmakers would need to revisit the issue in a future legislative session to impose statewide sales restrictions. Additional municipalities and county health districts across Idaho may weigh their own local measures in the meantime. Advocates for a statewide ban are expected to press the issue again when the Idaho Legislature reconvenes, particularly given the documented death toll and the continued absence of federal regulation from the FDA.